Q2 FY2026 EarningsQ2 FY26 beat consensus across all major metrics, driven by double-digit organic growth in Diagnostic Information Services. Revenue reached $3.04B vs. $2.97B expected (+2.4%), and adjusted diluted EPS of $3.12 exceeded the $2.82 mean estimate by 10.6%. Guidance for full-year FY26 was raised, with revenue midpoint moving to $12.0B (up from $11.84B) and adjusted EPS to $11.15 (up from $10.73), well above current market expectations.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Quest Diagnostics(DGX) the Revenue is 3.043 B (+10.21%), Beat estimate;the EBIT is 502 M (+7.73%), Beat estimate;the EPS is 2.84 (+14.98%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
3.04B10.21%
2.97B7.67%
+0.07B2.54%
EBITExceed expectations
0.50B7.73%
0.49B4.83%
+0.01B2.90%
EPSExceed expectations
2.8414.98%
2.52742.33%
+0.312612.65%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf